Hysteroscopic Endometrial Ablation as a Treatment for Abnormal Uterine Bleeding in Patients with Renal Transplants
article
OA: green
CC0
AI-generated summary
This paper describes hysteroscopic endometrial ablation as a treatment option for abnormal uterine bleeding in patients who have received kidney transplants.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Study objectiveTo assess the effectiveness and safety of hysteroscopic endometrial ablation as a surgical management of abnormal uterine bleeding that develops in patients with renal transplants.DesignRetrospective study (Canadian Task Force classification II-2).SettingYonsei University Medical College, Severance Hospital.PatientsSixty-two women with abnormal uterine bleeding who had undergone renal transplantation.InterventionHysteroscopic endometrial ablation.Measurements and main resultsFifty-four out of 62 patients (87.0%) who had undergone hysteroscopic endometrial ablation reported decreased bleeding (95% CI: 0.76 to 0.94): amenorrhea in 25 (40.3%), spotting in 19 (30.6%), and eumenorrhea in 10 (16.1%). Mean follow-up duration was 6 months. No complications related to the procedure were reported. Levonorgestrel-releasing intrauterine systems (LNG-IUSs) were inserted into eight patients who experienced continuous bleeding, five of whom showed symptomatic improvement: spotting in three (4.9%) and eumenorrhea in two (3.2%). The three patients (4.9%) in whom the LNG-IUS had no effect had hysterectomies, and the resultant pathologic findings were two cases of adenomyosis and one case of simple endometrial hyperplasia without atypia.ConclusionHysteroscopic endometrial ablation as a surgical management of abnormal uterine bleeding that develops in patients with renal transplants is an effective and safe procedure.
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (1)
References (26)
- Effect of the levonorgestrel-releasing intrauterine system on uterine myomas in a renal transplant patient via openalex
- W203746817 via openalex
- W1553057436 via openalex
- W1986517917 via openalex
- W1994814056 via openalex
- W1998419184 via openalex
- W2003083881 via openalex
- W2012604152 via openalex
- W2022453986 via openalex
- W2037729051 via openalex
- W2041648999 via openalex
- W2042374015 via openalex
- W2054019394 via openalex
- W2058287554 via openalex
- W2059326877 via openalex
- W2060296314 via openalex
- W2062997715 via openalex
- W2068719758 via openalex
- W2100129086 via openalex
- W2132330070 via openalex
- W2317405179 via openalex
- W2345491112 via openalex
- W2411036151 via openalex
- W2413320298 via openalex
- W200534921 via openalex
- W6608204243 via openalex
Source provenance
- europepmc
- last seen: 2026-09-16T06:11:32.772430+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:12:32.173627+00:00
License: CC0
· commercial use OK